The self-controlled case series (SCCS) method is a study design for investigating the association between a transient exposure and an adverse event. Although this method was originally developed to investigate the association between vaccines and adverse events (1, 2) , it has been used widely in pharmacoepidemiology and other areas of epidemiology (3) (4) (5) (6) (7) (8) . Specifically, SCCS is a case-only method in which only persons with an adverse event are considered. These cases act as their own controls; as such, confounders that do not vary over the individual's observation period, such as gender, genetic factors, and socioeconomic status, are implicitly adjusted for in the analysis.
Conditional Poisson regression models are used in the SCCS design to estimate an incidence rate ratio (IRR), defined as the ratio of the incidence rate in the risk period to the incidence rate in the unexposed control period(s). While these models perform well with large or moderate case samples, adverse events are rare in most vaccine safety studies, and maximum likelihood estimates (MLEs) may be biased (9, 10) . Several bias correction methods have been studied in generalized linear models for matched case-control studies (11) (12) (13) , but none of these correction methods have been evaluated in the SCCS study design.
Our aim in this study was to investigate, in vaccine safety studies with rare adverse events using the SCCS design, the performance of 2 bias correction approaches: the Firth penalized maximum likelihood (ML) method (14) and Cordeiro and McCullagh's (CM) bias reduction method after ML estimation (15) .
MATERIALS AND METHODS
The SCCS design and asymptotic bias of the MLE The SCCS study design is derived from an underlying cohort study design. Only cases are included in the study, and each individual's follow-up time is partitioned into an exposed risk period and an unexposed control period(s). IRRs compare the incidence rate of adverse events in the risk period with the rate in the control period(s). The IRRs are estimated using conditional Poisson regression models, conditioning on the number of events and the exposure history experienced by each individual during a predetermined observation period.
Let t ijk be the person-time, λ ijk be the incidence rate, and n ijk be the number of adverse events experienced by an individual i in age group j and time period k during the course of the whole observation period. Conditioning on the total number of events n i ¼ P j;k n ijk , the log-likelihood for the SCCS design can be written in the following form (16) :
where α j is the age effect associated with age group j and β k is the exposure effect for the risk period k. In equation 1, l and m are used to represent j and k in the denominator. We use different subscripts because the denominator represents a summation over age groups and time intervals for an individual in the numerator. The parameters α j and β k are log IRRs. The MLEs of α and β can be obtained using standard statistical software such as STATA (17) and SAS (18) . The asymptotic bias of the MLE of β was derived by Musonda et al. (10) in a simplified scenario for the SCCS design. This simplified scenario assumed the following: no underlying age effect, only 1 postexposure risk period, the same observation period, a common risk period (t 1 ) for all cases, and a common control period (t 0 ) for all cases. Under this simplified SCCS setting, up to first order, the asymptotic bias for the MLE of β can be expressed as
where r = t 1 /(t 0 + t 1 ) is the ratio of the length of the risk period to the length of the observation period. Equation 2 shows that in the SCCS design, the asymptotic bias of the MLE cannot be neglected if n is small, and that the bias changes sharply when r is very close to 0 or 1 (i.e., with very short or very long risk periods relative to the defined observation period). Therefore, it is important to know whether existing bias correction methods such as Firth's penalized ML method (14) and the CM bias reduction method (15) can correct the asymptotic bias from the MLE in vaccine safety studies using an SCCS design when adverse events are rare or the risk period is short.
Statistical methods of bias correction
Sun et al. (13) have described how to address the bias of point estimators. There are 2 main approaches: a bias-correction method and a bias-prevention method. In the bias-correction method, represented by Cordeiro and McCullagh (15) , the biascorrected estimate is obtained by subtracting the first-order term in the asymptotic bias from the MLE. One main drawback of this approach is that it depends on the existence of the MLE. Often when a sample size is small, data separation occurs if no events are observed in one of the 2 groups defined by a dichotomous covariate (or no events are observed in either the risk period or the control period(s) in the SCCS design), and no MLE is produced.
The bias-prevention method proposed by Firth (14) eliminates first-order bias by solving a modified score equation. Therefore, the estimation does not depend on the existence of the MLE. Firth's idea has been applied in logistic regression (19, 20) to reduce the bias in cases of data separation and in Cox regression (21) to handle the problems of monotone likelihood, when at least 1 parameter estimate diverges to negative or positive infinity.
In this study, we evaluated the performance of Firth's biasprevention method and the CM bias-correction method for correcting MLE bias in studies using the SCCS design with rare adverse events.
Firth penalized ML method. The MLE of the regression parameter β is often obtained by solving the score equation @logL/@β ≡ U(β) = 0, where L is the likelihood function. The method developed by Firth (14) to reduce the small-sample bias of the MLE used a modified score equation:
where I(β) −1 is the inverse of the information matrix evaluated at β and "trace" is the sum of the diagonal elements of a matrix. The modified score function U(β)* is related to the penalized likelihood function: 
, where X is a design matrix for the explanatory variables such as age groups and vaccine exposure. For the logit link function, W ¼ diagfπ i ð1 Àπ i Þg, and ξ i ¼ 0:5Q ii ð2π i À 1Þ,π i is the probability of having an adverse event. For the log link function, W ¼ diagfe x iβ g, and ξ i = −0.5Q ii . Q ii is the ith diagonal element of Q, the asymptotic variance ofη i ¼ x iβ , where link function g(.) provides mapping between the linear predictor η and the mean of the data. Then the bias-corrected estimate is calculated asβ ¼β À bias ðβÞ (equation 5). This method also eliminates the first order of bias from ML estimation, and the bias calculation is straightforward. However, it is only available when the MLE exists.
Simulations
Simulation structure. We conducted a simulation study to evaluate the performance of these two bias correction methods in SCCS designs with rare adverse events. The procedure used to generate the data set followed the simulation structure described by Glanz et al. (9) . Briefly, we first created a vaccinated cohort population of 100,000 under the combination of the parameters as specified below. Then the cases were simulated using the probability model
, where p ijk is the probability of being a case for an individual i in age group j and time period k; φ is the intercept of the model, representing the estimate of the baseline incidence rate; α j is the age effect; β is the main parameter of interest; x equals 1 for an exposed period and 0 for an unexposed period; and t ijk represents person-time during the interval. In all simulations, the observation period was set to 365 days for all individuals. One thousand data sets were simulated for each scenario, and for each scenario we varied the following:
• Intercept coefficient φ: Ranged from −13 to −16. These values allowed the baseline incidence rates, exp(φ), to range from 1.13 × 10 −7 to 2.26 × 10 −6 per day. Thus, the events were rare, and the probability of a case's having more than 1 event during the observation period was very low.
• Length of the risk period (t 1 ) following exposure: 3 days (r = 0.008), 14 days (r = 0.038), 42 days (r = 0.115), or 180 days (r = 0.493), where r represents the ratio of the length of the risk period to the length of the observation period. These risk periods were chosen because they represent the range of risk periods used in actual vaccine studies. Examples of such risk periods and studies include: 1) a short 3-day risk period such as that used to examine fever and convulsions after diphtheria-tetanus-pertussis vaccination (24); 2) a moderate-length risk period of 14 days, which was used to study acute myocardial infarction after influenza vaccination (25); 3) long 42-day risk periods, which were used to study idiopathic thrombocytopenic purpura after measlesmumps-rubella vaccination (26) (27) (28) ; and 4) a very long risk period of 6 months to 1 year for conditions such as autism after measles-mumps-rubella vaccination (29) .
• True β: Set to 0, 0.693, 1.609, or 2.303. These values were equivalent to IRRs of 1, 2, 5, and 10, respectively.
• Age groups and age-specific relative incidences: 1-90 days (α 1 = 0, exp(α 1 ) = 1), 91-270 days (α 2 = 0.3, exp(α 2 ) = 1.35), or 271-365 days (α 3 = 0.1, exp(α 3 ) = 1.1).
Sample sizes (n) of 5, 10, 20, 50, 100, 200, or 500 cases were generated. These numbers represented the range of case scenarios we have seen in our vaccine studies, from very rare adverse events such as Guillain-Barré syndrome to uncommon events such as idiopathic thrombocytopenic purpura and intussusception, and to more common events such as fever and febrile seizures. Simulation evaluation. For each simulated data set, we obtained the MLE or corrected MLE of the log IRRs (i.e.,β) from 3 approaches: 1) using the SAS procedure PHREG, 2) using the Firth correction method from the SAS procedure PHREG with the Firth option specified, and 3) using the CM bias-correction method from equations 4 and 5. These 3 approaches were evaluated using the following measures: 
RESULTS

Simulation results
In our simulation study, the percentage of data sets with finite MLEs increased as the IRR increased and the length of the risk period increased (Figure 1 ). For risk periods of moderate length, 80%-100% of simulated data sets had finite MLEs when the number of cases exceeded 50 for a risk period of 14 days (r = 0.038) and when the number of cases exceeded 10 for a risk period of 42 days (r = 0.115), across the range of IRRs. However, for a short risk period of 3 days (r = 0.008), more than 100 cases were needed to achieve finite MLEs in 80% of the simulated data sets. In more extreme scenarios, such as n ≤ 10 and IRR < 5, only 5%-30% of the simulated data sets had finite MLEs for a risk period of 3 days. Figure 2 shows how the percent bias of the estimatedβ from true β varied by the number of cases, the length of the risk period, and the value of the IRR. In general, percent bias decreased as the number of cases increased. In simulations conducted under scenarios of IRR = 2 (β = 0.693) or IRR = 5 (β = 1.609) and when the number of cases was large (n = 200 and n = 500), our results demonstrated that the MLEs were very similar to Firth's corrected estimates, and both were unbiased (data not shown). Therefore, we focused on simulations with low numbers of cases (n ≤ 100). For the CM correction method, estimates for n = 100 cases were not calculated because of computational intensity and a lack of computer space.
When the IRR equalled 2, the percent bias decreased as the length of the risk period increased, and Firth's method produced fewer biased estimates than the CM and ML methods (Figure 2, parts A-D) . When the risk period was greater than 14 days, Firth's method and the CM method provided unbiased estimates with n ≥ 10 cases and n ≥ 20 cases, respectively. However, for a short risk period (e.g., 3 days), more than 100 cases were needed to obtain unbiased estimates.
When the risk period was 14 days, the percent bias decreased when the IRR increased (Figure 2, parts B , E, and F). Firth's bias correction method provided less biased estimates than the CM and ML methods when IRR equalled 2, and its performance was comparable to the CM method when IRR equalled 5 and 10. Figure 3 shows how the MSE of the estimatedβ varied by the number of cases, the length of the risk period, and the value of the IRR. The Firth method and the CM method produced a lower MSE than the ML method across all IRR values and all risk period variations when n was less than 50, and when n was 50 or more, all of the methods had MSEs close to zero.
When the IRR was 2, the Firth method had better MSEs than or similar MSEs as the CM method across all lengths of the risk period, except when the risk period was 3 days and n equalled 5 ( Figure 3 , parts A-D). When the risk period was 14 days and the IRR values varied (Figure 3 , parts B, E, and F), MSEs increased as IRRs increased for all of the methods, although only up to 10 cases were needed for MSEs to be near zero for the Firth correction method and the CM method, while more than 20 cases were needed for the ML method. Figure 4 shows that all of the methods provided similar and very good coverage probabilities across various lengths of the risk period (Figure 4 , parts A-D) and values of the IRR (Figure 4 , parts B, E, and F), with the exception of the short risk period (e.g., 3 days), where the coverage probability from the ML and CM methods was poor (<80%) for n ≤ 50. Table 1 shows the type I error rates for falsely detecting an increased risk when there is no true exposure effect. The type I error rates were under or close to the 5% nominal level, except for the CM method when the risk period was short (3 days) and n exceeded 20 cases.
Example: Safety of TIV in a pediatric population
We applied the Firth correction method for the SCCS design using data from a recent screening study of the safety of trivalent inactivated influenza vaccine (TIV) in children. Details on this study are provided elsewhere (30) . In short, Glanz et al. (30) identified a cohort of more than 66,000 children who had been vaccinated with TIV between the ages of 24 and 59 months. In this cohort, an SCCS analysis was conducted on 55 different clinical outcomes to identify possible signals of adverse events following vaccination with TIV. We obtained institutional review board approval from 4 of the 7 sites in the TIV safety study to use their electronic data in our examples.
For this study, the following adverse events were selected: hypotension, fever, sepsis, and rash. These conditions represent a combination of rare and common adverse events with risk periods of different lengths (0-2, 1-14, and 1-42 days). Table 2 shows the estimated IRRs (and 95% confidence intervals) and the corresponding P values derived from the ML, Firth, and CM methods. For a common adverse event, such as fever, the estimated IRRs and P values from all 3 methods were very similar. For rare adverse events, the estimated IRRs from the Firth and CM methods were similar, but they were different from those obtained using the ML method. It is important to note that the observation period in this example study was 90 days for adverse events with risk windows of 0-2 days and 1-14 days and 180 days for a risk window of 1-42 days. Because of this, the r values were not as extreme as those we demonstrated in the simulation. SAS code for analyzing SCCS data using the Firth correction method is provided in the Appendix.
DISCUSSION
The aim of this study was to investigate the performance of bias correction approaches in SCCS studies, focusing on scenarios with small numbers of adverse events. We evaluated the bias-corrected MLEs of the log IRR from 2 methods-the Firth penalized ML method and Cordeiro and McCullagh's bias correction method after ML estimation. We conducted our evaluation using both simulated and published vaccine safety data.
The findings from our simulation studies showed that the bias in SCCS analyses is small when the number of cases is greater than 50 and the ratio between the risk period and the total observation period r is at least 0.05. These findings are consistent with what Musonda et al. found with MLEs (10). The most significant drawback of the ML method and the CM biascorrection method is that they are not available when MLEs do not exist, which is often the case when adverse events are rare in the SCCS design. For example, MLEs do not exist when there is no event in either the risk period or the control period. We also demonstrated that as the number of cases decreases or the length of the risk period decreases, fewer simulated data sets had finite MLEs. In contrast, estimates from the Firth penalized maximum likelihood method are always finite and are comparable to those obtained from the CM method. The Firth approach consistently outperforms the ML method across the scenarios we examined. These results were consistent when the methods were applied to actual vaccine safety data. In addition, since the Firth penalized ML method has been implemented in the PHREG procedure in SAS, one can easily obtain the Firthcorrected estimates without extra programming effort. Our simulation study also showed that the biases of estimates were very sensitive to short risk periods of 3 days, regardless of risk levels and the number of cases we examined. Because choosing an appropriate risk period and total observation time is very important in vaccine safety studies with the SCCS design, our findings suggest that for adverse events with short risk periods, one may consider choosing a shorter total observation period as well, so that r is at least greater than 0.05.
In the examples we provided from a recent safety study of TIV in children (30) , although the estimates for the rare adverse events changed across the methods, the magnitude of change was not great and the interpretation of the results remained the same. However, there are situations where use of the Firth method could change the estimate appreciably and possibly change the interpretation of results. Such situations are most likely to occur when there are no cases in either the risk window or the control window, when there is an extremely small number of events in either window, or when there is a short risk period. This study had a number of limitations. First, although the Firth correction method can always provide a finite estimate, bias still exists under the extreme scenarios, such as very rare events in a short risk period. However, the bias is always less than that produced by the ML and CM methods. Second, we focused only on the bias introduced by the ML method for small sample sizes and did not consider other sources of bias, such as misclassification or confounding. Third, several factors, such as unmeasured fixed confounding and time-varying seasonality, were not included in our simulation design. Additional studies are required to explore the impact of these factors on bias correction methods. Last, we only examined values of r ranging from 0.008 (risk period = 3 days) to 0.493 (risk period = 180 days), because these values represent a typical scenario for the risk period in vaccine safety studies; we did not explore the extreme value of r close to 1. As Musonda et al. demonstrated in their study (10) , bias increases when r is close to 1, and we would expect that a similar pattern would be observed using our simulations.
In summary, we believe these results have important implications for observational postmarketing studies of vaccine safety. Such studies require very large patient populations, often derived from electronic heath-record databases. In studies with fewer than 100 cases, our results demonstrate that the bias correction method should be carefully considered when using the SCCS 
